Symbol="ALLR"
AssetType="Common Stock"
Name="Allarity Therapeutics Inc"
Description="Allarity Therapeutics A / S develops various therapeutic candidates for the treatment of cancer using complementary drug-specific diagnostics (cDx) generated by its drug response prediction technology. The company is headquartered in Horsholm, Denmark."
CIK="1860657"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="210 BROADWAY, SUITE 201, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="2513500"
EBITDA="-16202000"
PERatio="0.0056"
PEGRatio="None"
BookValue="-104.41"
DividendPerShare="0"
DividendYield="0"
EPS="520"
RevenuePerShareTTM="-0.018"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.462"
ReturnOnEquityTTM="-1.975"
RevenueTTM="-7127000"
GrossProfitTTM="-36348000"
DilutedEPSTTM="520"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="5"
TrailingPE="0.0056"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="2.659"
EVToRevenue="-"
EVToEBITDA="-0.0989"
Beta="-0.0032"
num_52WeekHigh="2435.86"
num_52WeekLow="2.85"
num_50DayMovingAverage="8.61"
num_200DayMovingAverage="331.7"
SharesOutstanding="860790"
DividendDate="None"
ExDividendDate="None"
symbol="ALLR"
open="2.91"
high="3.00"
low="2.86"
price="2.97"
volume="200223.00"
latest_trading_day="2023-07-21"
previous_close="2.92"
change="0.05"
change_percent="1.7123%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="4111069"
Change_recent_avg="-0.01"
Delta_recent_avg="0.28"
Variance_recent_avg="0.14"
Change_ratio_recent_avg="-3.31"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="1164"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0198.jpeg"
image_negative_thumbnail_id_2="1104"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0137.jpeg"
image_neutral_thumbnail_id_1="598"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0001.jpeg"
image_neutral_thumbnail_id_2="531"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0068.jpeg"
image_positive_thumbnail_id_1="691"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0017.jpeg"
image_positive_thumbnail_id_2="616"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0092.jpeg"
image_professor_thumbnail_id_1="1200"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
image_professor_thumbnail_id_2="1186"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
